Orexo AB Announces New Partner For The Commercialization Of Zubsolv® In The United States

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Uppsala, Sweden – May 20, 2014 – Orexo AB announces a new partnership between Orexo US, Inc. and inVentiv Health for the commercialization of Zubsolv in the US. The new partnership agreement replaces existing contracts and will become effective July 1st, 2014 and has a three year term.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC